<DOC>
	<DOCNO>NCT00242047</DOCNO>
	<brief_summary>An open label , randomize , control , equivalency trial compare efficacy percutaneous route administration intradermal route administration Japanese ( Tokyo ) 172 BCG , prevention tuberculosis first two year life .</brief_summary>
	<brief_title>Randomized Controlled Trial Percutaneous Intradermal BCG Vaccination .</brief_title>
	<detailed_description>This open label , randomize , control , equivalency trial compare efficacy percutaneous route administration intradermal route administration Japanese ( Tokyo ) 172 BCG , obtain BCG laboratory Tokyo , Japan , prevention tuberculosis , bacteriological histological confirmation , meet strict clinical criterion , first two year life . The comparison two method necessary intradermal method almost universally preferred , without direct evidence clinical trial . The intradermal method provide accurate dose produce high rate tuberculin skin test conversion , neither factor show correlate efficacy BCG vaccination . The percutaneous method much simpler , show equally effective , could become preferred method . The Japanese strain choose one commercially available strain produce intradermal percutaneous administration , seed lot strain previously use produce BCG South African BCG vaccination program .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>1 . The child must eligible receive routine BCG vaccination . 2 . The child must bear one five hospital take part study resident study area . 3 . The mother must opportunity become informed study , either prenatal class followup visit , time situation permit , mother present hospital birth facility child bear . 4 . After informed study , mother give consent infant enrol sign consent form . 1 . The mother fail give inform consent . 2 . The child medical condition contraindicates vaccination first 24 hour life ( e.g. , birth weight 2,500 gram ) . 3 . The infant hospitalize outside study area vaccination give ( e.g . transfer hospital Cape Town respiratory distress ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>November 2004</verification_date>
	<keyword>Tuberculosis .</keyword>
	<keyword>Children .</keyword>
	<keyword>Vaccine .</keyword>
	<keyword>BCG .</keyword>
</DOC>